Scholar Rock, Inc.
2 registered trials on this site, 0 active. This page lists the trials this organization is registered as lead sponsor of, for the compounds covered on PeptideBlog.net. It is a registry listing, not an assessment of the company or its products.
Compounds covered
Registered trials
| Trial | Compound | Phase | Status | Sponsor | Enrolled | Primary completion | Registry updated |
|---|---|---|---|---|---|---|---|
| Efficacy and Safety of Apitegromab for the Treatment of Adults Who Are Overweight or Obese NCT06445075 | Apitegromab | Phase 2 | Completed | Scholar Rock, Inc. | 102 | Mar 4, 2025 | Jan 23, 2026 |
| Efficacy and Safety of Apitegromab in Patients With Later-Onset Spinal Muscular Atrophy Treated With Nusinersen or Risdiplam NCT05156320 | Apitegromab | Phase 3 | Completed | Scholar Rock, Inc. | 188 | Dec 18, 2024 | Jan 22, 2026 |
Data: ClinicalTrials.gov, U.S. National Library of Medicine. See the full trial tracker.
